Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01266967 · BASELINE

Baseline characteristics

A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain · Source last updated 2014-05-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      89
    2. group Id
      BG001
      value
      83
    3. group Id
      BG002
      value
      172
    units
    Participants
groups
  1. description
    Participants who received no prior local therapy for brain metastasis received GSK2118436 150 milligram (mg) capsules either one hour before or 2 hours after a meal twice daily until evidence of disease progression, death, or unacceptable adverse events.
    id
    BG000
    title
    GSK2118436 150 mg: No Prior Local Therapy
  2. description
    Participants who received prior local therapy for brain metastasis received GSK2118436 150 mg capsules either one hour before or 2 hours after a meal twice daily until evidence of disease progression, death, or unacceptable adverse events.
    id
    BG001
    title
    GSK2118436 150 mg: Prior Local Therapy
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          13.35
          value
          52.3
        2. group Id
          BG001
          spread
          13.83
          value
          52.7
        3. group Id
          BG002
          spread
          13.55
          value
          52.5
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          24
        2. group Id
          BG001
          value
          28
        3. group Id
          BG002
          value
          52
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          65
        2. group Id
          BG001
          value
          55
        3. group Id
          BG002
          value
          120
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          89
        2. group Id
          BG001
          value
          82
        3. group Id
          BG002
          value
          171
      title
      White
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          1
      title
      Not reported
    description
    Race was not reported for one participant who recevied prior local therapy.
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      89
    2. group Id
      BG001
      value
      83
    3. group Id
      BG002
      value
      172
    units
    Participants
groups
  1. description
    Participants who received no prior local therapy for brain metastasis received GSK2118436 150 milligram (mg) capsules either one hour before or 2 hours after a meal twice daily until evidence of disease progression, death, or unacceptable adverse events.
    id
    BG000
    title
    GSK2118436 150 mg: No Prior Local Therapy
  2. description
    Participants who received prior local therapy for brain metastasis received GSK2118436 150 mg capsules either one hour before or 2 hours after a meal twice daily until evidence of disease progression, death, or unacceptable adverse events.
    id
    BG001
    title
    GSK2118436 150 mg: Prior Local Therapy
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          13.35
          value
          52.3
        2. group Id
          BG001
          spread
          13.83
          value
          52.7
        3. group Id
          BG002
          spread
          13.55
          value
          52.5
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          24
        2. group Id
          BG001
          value
          28
        3. group Id
          BG002
          value
          52
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          65
        2. group Id
          BG001
          value
          55
        3. group Id
          BG002
          value
          120
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          89
        2. group Id
          BG001
          value
          82
        3. group Id
          BG002
          value
          171
      title
      White
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          1
      title
      Not reported
    description
    Race was not reported for one participant who recevied prior local therapy.
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice